Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000247830> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2000247830 endingPage "S192" @default.
- W2000247830 startingPage "S192" @default.
- W2000247830 abstract "This article is part of a Special Issue Hormones & Neurotrauma.This review describes the neuroendocrinological aspects of catamenial epilepsy, a menstrual cycle-related seizure disorder in women with epilepsy. Catamenial epilepsy is a multifaceted neuroendocrine condition in which seizures are clustered around specific points in the menstrual cycle, most often around perimenstrual or periovulatory period. Three types of catamenial seizures (perimenstrual, periovulatory and inadequate luteal) have been identified. The molecular pathophysiology of catamenial epilepsy remains unclear. Cyclical changes in the circulating levels of estrogens and progesterone (P) play a central role in the development of catamenial epilepsy. Endogenous neurosteroids such as allopregnanolone (AP) and allotetrahydrodeoxycorticosterone (THDOC) that modulate seizure susceptibility could play a critical role in catamenial epilepsy. In addition, plasticity in GABA-A receptor subunits could play a role in the enhanced seizure susceptibility in catamenial epilepsy. P-derived neurosteroids such as AP and THDOC potentiate synaptic GABA-A receptor function and also activate extrasynaptic GABA-A receptors in the hippocampus and thus may represent endogenous regulators of catamenial seizure susceptibility. Experimental studies have shown that neurosteroids confer greater seizure protection in animal models of catamenial epilepsy, especially without evident tolerance to their actions during chronic therapy. In the recently completed NIH-sponsored, placebo controlled phase 3 clinical trial, P therapy proved to be beneficial only in women with perimenstrual catamenial epilepsy but not in non-catamenial subjects. Neurosteroid analogs with favorable profile may be useful in the treatment of catamenial epilepsy." @default.
- W2000247830 created "2016-06-24" @default.
- W2000247830 creator A5062085807 @default.
- W2000247830 creator A5089587800 @default.
- W2000247830 date "2008-08-01" @default.
- W2000247830 modified "2023-09-24" @default.
- W2000247830 title "S.24.04 Neuroactive steroids in affective disorders" @default.
- W2000247830 doi "https://doi.org/10.1016/s0924-977x(08)70209-8" @default.
- W2000247830 hasPublicationYear "2008" @default.
- W2000247830 type Work @default.
- W2000247830 sameAs 2000247830 @default.
- W2000247830 citedByCount "0" @default.
- W2000247830 crossrefType "journal-article" @default.
- W2000247830 hasAuthorship W2000247830A5062085807 @default.
- W2000247830 hasAuthorship W2000247830A5089587800 @default.
- W2000247830 hasConcept C126322002 @default.
- W2000247830 hasConcept C134018914 @default.
- W2000247830 hasConcept C143228043 @default.
- W2000247830 hasConcept C15744967 @default.
- W2000247830 hasConcept C168258287 @default.
- W2000247830 hasConcept C169760540 @default.
- W2000247830 hasConcept C170493617 @default.
- W2000247830 hasConcept C2775858608 @default.
- W2000247830 hasConcept C2778186239 @default.
- W2000247830 hasConcept C2778338918 @default.
- W2000247830 hasConcept C2778460930 @default.
- W2000247830 hasConcept C2779058012 @default.
- W2000247830 hasConcept C44796713 @default.
- W2000247830 hasConcept C71315377 @default.
- W2000247830 hasConcept C71924100 @default.
- W2000247830 hasConceptScore W2000247830C126322002 @default.
- W2000247830 hasConceptScore W2000247830C134018914 @default.
- W2000247830 hasConceptScore W2000247830C143228043 @default.
- W2000247830 hasConceptScore W2000247830C15744967 @default.
- W2000247830 hasConceptScore W2000247830C168258287 @default.
- W2000247830 hasConceptScore W2000247830C169760540 @default.
- W2000247830 hasConceptScore W2000247830C170493617 @default.
- W2000247830 hasConceptScore W2000247830C2775858608 @default.
- W2000247830 hasConceptScore W2000247830C2778186239 @default.
- W2000247830 hasConceptScore W2000247830C2778338918 @default.
- W2000247830 hasConceptScore W2000247830C2778460930 @default.
- W2000247830 hasConceptScore W2000247830C2779058012 @default.
- W2000247830 hasConceptScore W2000247830C44796713 @default.
- W2000247830 hasConceptScore W2000247830C71315377 @default.
- W2000247830 hasConceptScore W2000247830C71924100 @default.
- W2000247830 hasLocation W20002478301 @default.
- W2000247830 hasOpenAccess W2000247830 @default.
- W2000247830 hasPrimaryLocation W20002478301 @default.
- W2000247830 hasRelatedWork W1970741519 @default.
- W2000247830 hasRelatedWork W199080563 @default.
- W2000247830 hasRelatedWork W2014945515 @default.
- W2000247830 hasRelatedWork W2020167192 @default.
- W2000247830 hasRelatedWork W2029866480 @default.
- W2000247830 hasRelatedWork W2036690788 @default.
- W2000247830 hasRelatedWork W2047157308 @default.
- W2000247830 hasRelatedWork W2061012355 @default.
- W2000247830 hasRelatedWork W2128168682 @default.
- W2000247830 hasRelatedWork W3004451854 @default.
- W2000247830 hasVolume "18" @default.
- W2000247830 isParatext "false" @default.
- W2000247830 isRetracted "false" @default.
- W2000247830 magId "2000247830" @default.
- W2000247830 workType "article" @default.